Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Saputo Announces Election of Directors
-
BRT Apartments Corp. Files Second Quarter 2024 Financial Statements
-
Catalyst Accelerator Ogden Selects 11 Companies for Fall 2024 Cohort in Partnership with the Department of the Air Force Digital Transformation Office
-
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
-
Artisan Partners Asset Management Inc. Reports July 2024 Assets Under Management
-
INFINT Acquisition Corporation Announces Intention to Voluntarily Delist from NYSE American LLC, Conditional Upon Consummation of its Pending Business Combination with Seamless Group Inc.
-
Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
-
Motorsport Games Reports Second Quarter 2024 Financial Results
-
FutureFuel Releases Second Quarter 2024 Results
-
Zscaler to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call
-
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
-
Gencor Releases Third Quarter Fiscal 2024 Results
-
Humacyte Announces FDA Communication of Additional Time Required to Complete Review of acellular tissue engineered vessel (ATEV™) BLA for the Treatment of Vascular Trauma
-
Fly-E Group, Inc. Launches E-Bike Rental Service to Address Growing Market Demand and Participates in NYC’s Trade-In Program
-
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Globalink Investment Inc. Announces Extension of the Deadline to Complete a Business Combination to September 9, 2024
-
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability to Target Injury and Inflammation Sites – New Study
-
NurExone's ExoPTEN, loaded with siRNA, Demonstrates Ability to Target Injury and Inflammation Sites – New Study
-
Symbotic Acquires Veo Robotics to Enhance Efficiency and Safety Innovation
-
Hemp Seed Meal achieves monumental milestone through AAFCO and FDA-CVM
-
Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering
-
ZipBy, Fennix, and EasyPark Pioneering Automatic Payment and Gate Entry System Across Vancouver
-
GWTI Name Robert Kevin Jones President
-
Nokia Corporation: Repurchase of own shares on 09.08.2024
-
Pacira BioSciences Comments on Ruling on EXPAREL Patent Litigation from U.S. District Court for the District of New Jersey
-
Norwegian Cruise Line Holdings Contributes $50,000 to Accelerate Flood Relief Efforts in Juneau, Alaska
-
Sanofi: Information concerning the total number of voting rights and shares - July 2024
-
GWTI’s Stock Converted from Trading on OTCQB to Pink Sheet Trading
-
Tshan Markets, the Revolutionary Online Trading Platform officially launched
-
Rogers Sugar Inc. Declares Dividend To Shareholders
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
Parks! America, Inc. to Hold Third Quarter Fiscal 2024 Earnings Conference Call on August 13, 2024
-
United Steelworkers endorse the NDP candidate Leila Dance in Elmwood-Transcona by-election
-
OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X
-
End of Day Message
-
CIRB Moves Strike or Lockout Deadline at CN and CPKC to August 22, say Teamsters
-
Transaction in Own Shares
-
Lee Health Embraces AI to Support Patient Care, Improve Health Outcomes, and Increase Efficiency
-
Genius Group Founder & CEO Roger James Hamilton to Purchase up to 10 Million Shares
-
Genius Group Founder & CEO Roger James Hamilton to Purchase up to 10 Million Shares
-
The Art Institute & 900 North Michigan Shops Make Georgia O’Keeffe: “My New Yorks,” Accessible to All Via Midwest’s Largest Canvas for Digital Art August 9 - September 22, 2024
-
The Art Institute & 900 North Michigan Shops Make Georgia O’Keeffe: “My New Yorks,” Accessible to All Via Midwest’s Largest Canvas for Digital Art August 9 - September 22, 2024
-
Segway Boosts Paris’s Sustainable Mobility with Summer Free Ride Campaign
-
EnBW International Finance B.V.: Half-yearly report
-
ARS Pharmaceuticals Receives FDA Approval of neffy® (epinephrine nasal spray), the First and Only Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
-
Solvay: acquisition of own shares
-
ABO-Group Environment: 2 more French companies added
